Europe Biological Skin Substitutes Market Size, Share & Trends Analysis Report By Type, By End Use, By Application, By Country and Growth Forecast, 2024 - 2031

The Europe Biological Skin Substitutes Market would witness market growth of 8.4% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Biological Skin Substitutes Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $38,847.8 Thousands by 2031. The UK market is exhibiting a CAGR of 7.4% during (2024 - 2031). Additionally, The France market would experience a CAGR of 9.5% during (2024 - 2031).

The expanding geriatric population is a major factor driving growth in the biological skin substitutes market, as aging individuals are more prone to chronic wounds due to reduced skin elasticity, slower cell regeneration, and diminished collagen production. These physiological changes increase susceptibility to pressure sores, diabetic foot ulcers, and venous leg ulcers, often requiring more advanced wound care solutions than traditional dressings.

Additionally, biological skin substitutes provide a protective layer that supports the natural healing process by mimicking the structure of human skin and creating an environment conducive to tissue repair. This is especially advantageous for elderly patients who may not possess the regenerative capacity required for conventional wound treatments.

The European market for biological skin substitutes is characterized by strong government support for healthcare advancements and a well-established regulatory framework. Countries across Europe, particularly in Western Europe, benefit from robust healthcare systems that support the adoption of advanced wound care solutions. The region’s focus on reducing healthcare costs and improving outcomes for chronic disease patients drives the demand for biological skin substitutes.

Free Valuable Insights: The Global Biological Skin Substitutes Market will Hit USD 568.3 Million by 2031, at a CAGR of 8.6%

Based on Type, the market is segmented into Human Donor Tissue-derived Products and Acellular Animal-derived Products. Based on End Use, the market is segmented into Hospitals, Outpatient Facilities, and Research & Manufacturing. Based on Application, the market is segmented into Acute Wounds and Chronic Wounds. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Smith & Nephew plc
• Stryker Corporation
• MIMEDX Group, Inc.
• Organogenesis Holdings, Inc.
• Integra LifeSciences Corporation
• 3M Company
• Essity AB (BSN Medical)
• Zimmer Biomet Holdings, Inc.
• Vericel Corporation
• Molnlycke Health Care AB

Europe Biological Skin Substitutes Market Report Segmentation

By Type

• Human Donor Tissue-derived Products
• Acellular Animal-derived Products

By End Use

• Hospitals
• Outpatient Facilities
• Research & Manufacturing

By Application

• Acute Wounds
• Chronic Wounds

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Biological Skin Substitutes Market, by Type
1.4.2 Europe Biological Skin Substitutes Market, by End Use
1.4.3 Europe Biological Skin Substitutes Market, by Application
1.4.4 Europe Biological Skin Substitutes Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Porter Five Forces Analysis

Chapter 5. Europe Biological Skin Substitutes Market by Type
5.1 Europe Human Donor Tissue-derived Products Market by Country
5.2 Europe Acellular Animal-derived Products Market by Country

Chapter 6. Europe Biological Skin Substitutes Market by End Use
6.1 Europe Hospitals Market by Country
6.2 Europe Outpatient Facilities Market by Country
6.3 Europe Research & Manufacturing Market by Country

Chapter 7. Europe Biological Skin Substitutes Market by Application
7.1 Europe Acute Wounds Market by Country
7.2 Europe Chronic Wounds Market by Country

Chapter 8. Europe Biological Skin Substitutes Market by Country
8.1 Germany Biological Skin Substitutes Market
8.1.1 Germany Biological Skin Substitutes Market by Type
8.1.2 Germany Biological Skin Substitutes Market by End Use
8.1.3 Germany Biological Skin Substitutes Market by Application
8.2 UK Biological Skin Substitutes Market
8.2.1 UK Biological Skin Substitutes Market by Type
8.2.2 UK Biological Skin Substitutes Market by End Use
8.2.3 UK Biological Skin Substitutes Market by Application
8.3 France Biological Skin Substitutes Market
8.3.1 France Biological Skin Substitutes Market by Type
8.3.2 France Biological Skin Substitutes Market by End Use
8.3.3 France Biological Skin Substitutes Market by Application
8.4 Russia Biological Skin Substitutes Market
8.4.1 Russia Biological Skin Substitutes Market by Type
8.4.2 Russia Biological Skin Substitutes Market by End Use
8.4.3 Russia Biological Skin Substitutes Market by Application
8.5 Spain Biological Skin Substitutes Market
8.5.1 Spain Biological Skin Substitutes Market by Type
8.5.2 Spain Biological Skin Substitutes Market by End Use
8.5.3 Spain Biological Skin Substitutes Market by Application
8.6 Italy Biological Skin Substitutes Market
8.6.1 Italy Biological Skin Substitutes Market by Type
8.6.2 Italy Biological Skin Substitutes Market by End Use
8.6.3 Italy Biological Skin Substitutes Market by Application
8.7 Rest of Europe Biological Skin Substitutes Market
8.7.1 Rest of Europe Biological Skin Substitutes Market by Type
8.7.2 Rest of Europe Biological Skin Substitutes Market by End Use
8.7.3 Rest of Europe Biological Skin Substitutes Market by Application

Chapter 9. Company Profiles
9.1 Smith & Nephew PLC
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional and Segmental Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Stryker Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 MiMedx Group. Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Research & Development Expenses
9.3.4 SWOT Analysis
9.4 Organogenesis Holdings, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expenses
9.5 Integra LifeSciences Holdings Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 3M Company
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Essity AB (BSN medical)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Zimmer Biomet Holdings, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Vericel Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
9.9.4 SWOT Analysis
9.10. Molnlycke Health Care AB
9.10.1 Company Overview
9.10.2 SWOT Analysis

TABLE 1 Europe Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 2 Europe Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 3 Europe Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 4 Europe Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 5 Europe Human Donor Tissue-derived Products Market by Country, 2020 - 2023, USD Thousands
TABLE 6 Europe Human Donor Tissue-derived Products Market by Country, 2024 - 2031, USD Thousands
TABLE 7 Europe Acellular Animal-derived Products Market by Country, 2020 - 2023, USD Thousands
TABLE 8 Europe Acellular Animal-derived Products Market by Country, 2024 - 2031, USD Thousands
TABLE 9 Europe Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 10 Europe Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 11 Europe Hospitals Market by Country, 2020 - 2023, USD Thousands
TABLE 12 Europe Hospitals Market by Country, 2024 - 2031, USD Thousands
TABLE 13 Europe Outpatient Facilities Market by Country, 2020 - 2023, USD Thousands
TABLE 14 Europe Outpatient Facilities Market by Country, 2024 - 2031, USD Thousands
TABLE 15 Europe Research & Manufacturing Market by Country, 2020 - 2023, USD Thousands
TABLE 16 Europe Research & Manufacturing Market by Country, 2024 - 2031, USD Thousands
TABLE 17 Europe Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 18 Europe Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 19 Europe Acute Wounds Market by Country, 2020 - 2023, USD Thousands
TABLE 20 Europe Acute Wounds Market by Country, 2024 - 2031, USD Thousands
TABLE 21 Europe Chronic Wounds Market by Country, 2020 - 2023, USD Thousands
TABLE 22 Europe Chronic Wounds Market by Country, 2024 - 2031, USD Thousands
TABLE 23 Europe Biological Skin Substitutes Market by Country, 2020 - 2023, USD Thousands
TABLE 24 Europe Biological Skin Substitutes Market by Country, 2024 - 2031, USD Thousands
TABLE 25 Germany Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 26 Germany Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 27 Germany Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 28 Germany Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 29 Germany Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 30 Germany Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 31 Germany Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 32 Germany Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 33 UK Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 34 UK Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 35 UK Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 36 UK Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 37 UK Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 38 UK Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 39 UK Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 40 UK Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 41 France Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 42 France Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 43 France Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 44 France Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 45 France Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 46 France Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 47 France Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 48 France Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 49 Russia Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 50 Russia Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 51 Russia Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 52 Russia Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 53 Russia Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 54 Russia Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 55 Russia Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 56 Russia Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 57 Spain Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 58 Spain Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 59 Spain Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 60 Spain Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 61 Spain Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 62 Spain Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 63 Spain Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 64 Spain Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 65 Italy Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 66 Italy Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 67 Italy Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 68 Italy Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 69 Italy Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 70 Italy Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 71 Italy Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 72 Italy Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 73 Rest of Europe Biological Skin Substitutes Market, 2020 - 2023, USD Thousands
TABLE 74 Rest of Europe Biological Skin Substitutes Market, 2024 - 2031, USD Thousands
TABLE 75 Rest of Europe Biological Skin Substitutes Market by Type, 2020 - 2023, USD Thousands
TABLE 76 Rest of Europe Biological Skin Substitutes Market by Type, 2024 - 2031, USD Thousands
TABLE 77 Rest of Europe Biological Skin Substitutes Market by End Use, 2020 - 2023, USD Thousands
TABLE 78 Rest of Europe Biological Skin Substitutes Market by End Use, 2024 - 2031, USD Thousands
TABLE 79 Rest of Europe Biological Skin Substitutes Market by Application, 2020 - 2023, USD Thousands
TABLE 80 Rest of Europe Biological Skin Substitutes Market by Application, 2024 - 2031, USD Thousands
TABLE 81 Key Information – Smith & Nephew PLC
TABLE 82 Key Information – Stryker Corporation
TABLE 83 Key Information – mimedx group inc
TABLE 84 Key Information – ORGANOGENESIS HOLDINGS, INC.
TABLE 85 Key Information – Integra Lifesciences Holdings Corporation
TABLE 86 Key Information – 3M Company
TABLE 87 Key Information – Essity AB
TABLE 88 Key Information – Zimmer Biomet Holdings, Inc.
TABLE 89 Key Information – Vericel Corporation
TABLE 90 Key Information – Molnlycke Health Care AB

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Biological Skin Substitutes Market, 2020 - 2031, USD Thousands
FIG 3 Key Factors Impacting Biological Skin Substitutes Market
FIG 4 Market Share Analysis, 2023
FIG 5 Porter’s Five Forces Analysis – Biological Skin Substitutes Market
FIG 6 Europe Biological Skin Substitutes Market share by Type, 2023
FIG 7 Europe Biological Skin Substitutes Market share by Type, 2031
FIG 8 Europe Biological Skin Substitutes Market by Type, 2020 - 2031, USD Thousands
FIG 9 Europe Biological Skin Substitutes Market share by End Use, 2023
FIG 10 Europe Biological Skin Substitutes Market share by End Use, 2031
FIG 11 Europe Biological Skin Substitutes Market by End Use, 2020 - 2031, USD Thousands
FIG 12 Europe Biological Skin Substitutes Market share by Application, 2023
FIG 13 Europe Biological Skin Substitutes Market share by Application, 2031
FIG 14 Europe Biological Skin Substitutes Market by Application, 2020 - 2031, USD Thousands
FIG 15 Europe Biological Skin Substitutes Market share by Country, 2023
FIG 16 Europe Biological Skin Substitutes Market share by Country, 2031
FIG 17 Europe Biological Skin Substitutes Market by Country, 2020 - 2031, USD Thousands
FIG 18 SWOT Analysis: Smith & Nephew PLC
FIG 19 SWOT Analysis: Stryker Corporation
FIG 20 Swot Analysis: MiMedx Group, Inc.
FIG 21 SWOT Analysis: Integra Lifesciences Holdings Corporation
FIG 22 SWOT Analysis: 3M Company
FIG 23 SWOT Analysis: Essity AB
FIG 24 SWOT Analysis: Zimmer Biomet Holdings, Inc.
FIG 25 Swot Analysis: Vericel Corporation
FIG 26 Swot Analysis: Molnlycke Health Care AB